In the present study, the absence of an association between HSD17B1 haplotypes and prostate cancer suggests that we can rule out large or moderate associations between common HSD17B1 variants and risk of prostate cancer among U.S. and European whites. This evidence concerns the gene HSD17B1 and Familial prostate cancer.